Drug Profile
Pyridoxalated haemoglobin polyoxyethylene
Alternative Names: Hemoximer; PHP; PHP-CT; PHP-HT; PHP-OC; Pyridoxalated haemoglobin polyethylene; VTR-PHPLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Ajinomoto
- Developer Curacyte Inc
- Class Haemoglobins; Polyethylene glycols
- Mechanism of Action Nitric oxide inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis; Septic shock; Shock
Most Recent Events
- 26 Aug 2011 Discontinued - Phase-II for Shock in USA (IV)
- 26 Aug 2011 Discontinued - Phase-III for Septic shock in European Union (IV)
- 03 Feb 2011 Pyridoxalated haemoglobin polyoxyethylene is still in phase III trials for Septic shock in the European Union